HY-125654A-1mg
|
MedChemexpress LLC
|
Olanexidine (hydrochloride) [CAS 146509-94-6]
|
|
|
|
HY-125654A-10mg
|
MedChemexpress LLC
|
Olanexidine (hydrochloride) [CAS 146509-94-6]
|
|
|
|
HY-125654A-100mg
|
MedChemexpress LLC
|
Olanexidine (hydrochloride) [CAS 146509-94-6]
|
|
|
|
HY-125654A-25mg
|
MedChemexpress LLC
|
Olanexidine (hydrochloride) [CAS 146509-94-6]
|
|
|
|
HY-125654A-5mg
|
MedChemexpress LLC
|
Olanexidine (hydrochloride) [CAS 146509-94-6]
|
|
|
|
HY-125654A-50mg
|
MedChemexpress LLC
|
Olanexidine (hydrochloride) [CAS 146509-94-6]
|
|
|
|
HY-101213-1mg
|
MedChemexpress LLC
|
OSW-1 [CAS 145075-81-6]
|
|
Cancer-programmed cell death
|
|
HY-101213-10mg
|
MedChemexpress LLC
|
OSW-1 [CAS 145075-81-6]
|
|
Cancer-programmed cell death
|
|
HY-101213-5mg
|
MedChemexpress LLC
|
OSW-1 [CAS 145075-81-6]
|
|
Cancer-programmed cell death
|
|
HY-10224-10mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-100mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-200mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-5mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-50mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-500mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-1mL
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-111422-10mg
|
MedChemexpress LLC
|
PLX51107 [CAS 1627929-55-8]
|
|
Cancer-programmed cell death
|
|
HY-111422-5mg
|
MedChemexpress LLC
|
PLX51107 [CAS 1627929-55-8]
|
|
Cancer-programmed cell death
|
|
HY-111422-50mg
|
MedChemexpress LLC
|
PLX51107 [CAS 1627929-55-8]
|
|
Cancer-programmed cell death
|
|
HY-111422-1mL
|
MedChemexpress LLC
|
PLX51107 [CAS 1627929-55-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-13814-10mg
|
MedChemexpress LLC
|
PR-619 [CAS 2645-32-1]
|
|
Cancer-programmed cell death
|
|
HY-13814-100mg
|
MedChemexpress LLC
|
PR-619 [CAS 2645-32-1]
|
|
Cancer-programmed cell death
|
|
HY-13814-5mg
|
MedChemexpress LLC
|
PR-619 [CAS 2645-32-1]
|
|
Cancer-programmed cell death
|
|
HY-13814-50mg
|
MedChemexpress LLC
|
PR-619 [CAS 2645-32-1]
|
|
Cancer-programmed cell death
|
|
HY-13814-1mL
|
MedChemexpress LLC
|
PR-619 [CAS 2645-32-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|